All In MedTech

FDA Clearance Tracker · P190016-S009

Tula® System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 31, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 31, 2025

Approved

Time to decision

177 days

Received Aug 7, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P190016-S009
Device name
Tula® System
Applicant location
Menlo Park, CA
Received
Aug 7, 2024
Decided
Jan 31, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P190016

Device type

Device class
Class III

Every decision under product code QJA

FDA's approval statement

As written in FDA's record.

approval for a manufacturing site located at, RxCrossroads (“Clermont Site”)170 Clermont RoadSuite AShepherdsville, KY 40165;which performs the final kitting of the Tula System Drug Pack and logistics distribution of the Tula System (Tula Kit, Drug Pack, and spares) to customers, on behalf of Tusker Medical.

Source documents

Other decisions for Tusker Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.